Riskpilot← Back to searchSign inGet full accessDoc Bon Cru AB
ABIn liquidationOrg 5565920427General medical practice activities · NACE 8621Est. 20000 employees
Revenue 2021
SEK 0
EBITDA margin
—
-94% vs 2019
Equity ratio
100.0%
Financial strength
Net profit 2021
SEK -91K
-94% vs 2019
| Revenue | SEK 0 | — |
| EBITDA | SEK -91K | -94% |
| Net profit | SEK -91K | -94% |
| Total assets | SEK 10K | -93% |
| Equity | SEK 10K | -90% |
| Employees | 0 | — |
Legal name
Doc Bon Cru AB
Org number
5565920427
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 september 2000
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-06-30
Financial year
January – December
Company purpose
Bolaget skall bedriva medicinsk diagnostik och behandling, förebyggande friskvård, utbildning, forskning och produktutveckling inom hälso- och sjukvård, direkt eller indirekt bedriva agentur, import och handel med vin och tillbehör, äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2021 |
|---|---|---|---|---|---|
| Revenue | 84 | 123 | 11 | 6 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −35 | 25 | −62 | −47 | −91 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −35 | 25 | −62 | −47 | −91 |
| Net financials | −1 | — | — | — | — |
| Profit before tax | −36 | 25 | −62 | −47 | −91 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −36 | 25 | −62 | −47 | −91 |
| Item | 2016 | 2017 | 2018 | 2019 | 2021 |
|---|---|---|---|---|---|
| Total assets | 177 | 234 | 161 | 139 | 10 |
| Equity | 96 | 122 | 100 | 100 | 10 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 80 | 113 | 60 | 38 | 0 |
| Total debt | 80 | 113 | 60 | 38 | — |
EBITDA margin
-9100000.0%
This company
15.8%
Market median
-57595037% vs market
20162021
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20162021
Return on equity
-910.0%
This company
18.4%
Market median
-5046% vs market
20162021
Net profit margin
-9100000.0%
This company
8.1%
Market median
-112345779% vs market
20162021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20162021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-01-01 – 2021-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
LG External Signatory | External Signatory | 2020 |
IM External Signatory | External Signatory | 2020 |
BJ Liquidator | Liquidator | 2020 |
UM External Signatory | External Signatory | 2020 |
| Former (2) | ||
MK External Signatory | External Signatory | 2020 – 2021 |
JD Audit | Audit | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doc Bon Cru AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Gustav Andersson | External Signatory | 0 companies |
| Inger Margareta Dahle | External Signatory | 0 companies |
| Bengt Junior Niklas Nygårds | Liquidator | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Mona Katarina Lundin | External Signatory | 0 companies |
| Jan Daniel Håkansson | Audit | 0 companies |
| Anna Katarina Lundin | Deputy Board Member | 0 companies |
| Olof Lars Magnus Lundin | Board of Directors | 0 companies |